Embolotherapy Market Analysis (2021-2028) – DataM Intelligence
The global Embolotherapy Market is expected to grow at a high CAGR during the forecasting period (2021-2028).
(EMAILWIRE.COM, October 19, 2021 )
Market Overview
Embolotherapy is a type of endovascular treatment aiming to block abnormal blood vessels to manage hurt, blood vessel malformations, revascularize organs, and scale back tumors. This blockage of blood vessels is called vascular occlusion.
For embolization to be successful, three considerations must be followed: embolic agent selection, clinical application, and technical ability. Stainless steel coils, absorbable gelatin pledges and powder, polyvinyl alcohol foam, ethanol, and glues are the main embolic agents used.
In the arterial system, both of these agents operate at various levels; for example, coils are similar to surgical ligation and block medium to small arteries, while liquid agents and particles of smaller diameter block at the level of the arteriolar or capillary bed. The type of agent selected, including trauma, cancers, male infertility, impotence, and vascular malformations, should also be determined according to clinical application.
Additionally, the adoption of embolic procedures for managing various diseases is increasing rapidly. Most of the patients diagnosed at the intermediate stage and advanced stage do not respond to curative therapies.
View full report: https://www.datamintelligence.com/research-report/embolotherapy-market
Market Dynamics
The global embolotherapy market growth is driven by the increasing target patient population of chronic diseases like Liver Cancer, Strokes.
The increasing target patient population of chronic diseases is expected to drive the growth in the forecast period
The increasing prevalence of several chronic diseases, including cancer, strokes is expected to drive the global Embolotherapy market during the forecasting period. According to the Centre for Disease Control and Prevention (CDC) reports 33,000 people in the US are diagnosed with liver cancer each year.
Among these, over 27,000 patients die from the illness and in which 24,000 men and 10,000 women get liver cancer, and about 18,000 men and 9,000 women die from the disease. Additionally, the percentage of people with liver cancer has steadily been increasing in the last decade. Moreover, the survival rate beyond five years remains extremely low, with the percentage hovering between 4 to 26.
On the other hand, Strokes remains the fifth-leading cause of death in the United States, with 7,95,000 cases reported annually, and every 40 seconds and every 4 minutes, someone dies of a stroke.
Reimbursement schemes provided by the government for minimally invasive surgeries are also driving market growth.
In high-income countries, where the government provides 60% healthcare insurance, it has led more people to get their surgeries done. Simultaneously, many low-income countries are also coming up with reimbursement plans to help the public.
In multiple Low-Middle Income Countries (LMICs), charitable organizations' equipment has enabled the practice of laparoscopic surgery. In LMICs, minimally invasive procedures for both emergency and elective courses are used. Due to the shortage of funding for equipment and repairs in certain parts of Africa, laparoscopic surgery is much more prevalent in private hospitals.
Market Segmentation:
By Product
• Microspheres
• Embolic coils
• Microcatheters
By Disease
• Oncology
• Aneurysm
• Peripheral vascular diseases
By End-user
• Hospitals
• Ambulatory Surgical centers
Download free sample: https://www.datamintelligence.com/download-sample/embolotherapy-market
Geographical Analysis
Asia-Pacific region holds the largest market share in global embolotherapy market
Asia- Pacific holds the largest share in the market. The reason is that the CDC reports that Australia is the leading country with 468 cases of cancer per 100,000 population, followed by New Zealand and Ireland. The reason can be attributed to fast-growing industrialization and the growing consumption of alcohol and drugs. Since the target audience is prominent in Asia- Pacific region, the embolotherapy market demand is most prominent in this region.
North America is reported to be the second-largest shareholder of the market; the decrease in cancer cases is because govt. Of United States is investing a lot towards reducing the cancer cases stats. The U.S. Preventive Services Task Force (USPSTF) routinely carries out comprehensive reviews of the efficacy of clinical prevention services, and the U.S. The Community Preventive Services Task Force assesses the effectiveness of programs affecting populations.
Competitive Landscape
The global embolotherapy market is quite competitive with some key competitors like Boston Scientific Corporation, Merit Medical Systems, Terumo Corporation, Medtronic plc, Johnson & Johnson, Stryker Corporation, BTG plc, Penumbra, Inc., Cook Medical, Abbott Laboratories. The growth of these companies is attributed to product launch, acquisition of independent companies, and investments in multiple sectors.
For example, Terumo acquired the 3M Company's cardiovascular division in July 1999 and founded Terumo Cardiovascular Systems Corp. in the USA. The company made two more acquisitions in 2001: it acquired Sumitomo Bakelite Co., Ltd.'s home oxygen division, and founded Japan's Terumo Medical Care K.K. and Ikiken Co., Ltd., and more.
Topic's you may be interested, Hematocrit Test Devices Market, Hematology Testing Products Market, Haemodialysis Equipment Market, Infectious Disease Testing Products Market, Cardiometabolic Monitoring Products Market
Market Overview
Embolotherapy is a type of endovascular treatment aiming to block abnormal blood vessels to manage hurt, blood vessel malformations, revascularize organs, and scale back tumors. This blockage of blood vessels is called vascular occlusion.
For embolization to be successful, three considerations must be followed: embolic agent selection, clinical application, and technical ability. Stainless steel coils, absorbable gelatin pledges and powder, polyvinyl alcohol foam, ethanol, and glues are the main embolic agents used.
In the arterial system, both of these agents operate at various levels; for example, coils are similar to surgical ligation and block medium to small arteries, while liquid agents and particles of smaller diameter block at the level of the arteriolar or capillary bed. The type of agent selected, including trauma, cancers, male infertility, impotence, and vascular malformations, should also be determined according to clinical application.
Additionally, the adoption of embolic procedures for managing various diseases is increasing rapidly. Most of the patients diagnosed at the intermediate stage and advanced stage do not respond to curative therapies.
View full report: https://www.datamintelligence.com/research-report/embolotherapy-market
Market Dynamics
The global embolotherapy market growth is driven by the increasing target patient population of chronic diseases like Liver Cancer, Strokes.
The increasing target patient population of chronic diseases is expected to drive the growth in the forecast period
The increasing prevalence of several chronic diseases, including cancer, strokes is expected to drive the global Embolotherapy market during the forecasting period. According to the Centre for Disease Control and Prevention (CDC) reports 33,000 people in the US are diagnosed with liver cancer each year.
Among these, over 27,000 patients die from the illness and in which 24,000 men and 10,000 women get liver cancer, and about 18,000 men and 9,000 women die from the disease. Additionally, the percentage of people with liver cancer has steadily been increasing in the last decade. Moreover, the survival rate beyond five years remains extremely low, with the percentage hovering between 4 to 26.
On the other hand, Strokes remains the fifth-leading cause of death in the United States, with 7,95,000 cases reported annually, and every 40 seconds and every 4 minutes, someone dies of a stroke.
Reimbursement schemes provided by the government for minimally invasive surgeries are also driving market growth.
In high-income countries, where the government provides 60% healthcare insurance, it has led more people to get their surgeries done. Simultaneously, many low-income countries are also coming up with reimbursement plans to help the public.
In multiple Low-Middle Income Countries (LMICs), charitable organizations' equipment has enabled the practice of laparoscopic surgery. In LMICs, minimally invasive procedures for both emergency and elective courses are used. Due to the shortage of funding for equipment and repairs in certain parts of Africa, laparoscopic surgery is much more prevalent in private hospitals.
Market Segmentation:
By Product
• Microspheres
• Embolic coils
• Microcatheters
By Disease
• Oncology
• Aneurysm
• Peripheral vascular diseases
By End-user
• Hospitals
• Ambulatory Surgical centers
Download free sample: https://www.datamintelligence.com/download-sample/embolotherapy-market
Geographical Analysis
Asia-Pacific region holds the largest market share in global embolotherapy market
Asia- Pacific holds the largest share in the market. The reason is that the CDC reports that Australia is the leading country with 468 cases of cancer per 100,000 population, followed by New Zealand and Ireland. The reason can be attributed to fast-growing industrialization and the growing consumption of alcohol and drugs. Since the target audience is prominent in Asia- Pacific region, the embolotherapy market demand is most prominent in this region.
North America is reported to be the second-largest shareholder of the market; the decrease in cancer cases is because govt. Of United States is investing a lot towards reducing the cancer cases stats. The U.S. Preventive Services Task Force (USPSTF) routinely carries out comprehensive reviews of the efficacy of clinical prevention services, and the U.S. The Community Preventive Services Task Force assesses the effectiveness of programs affecting populations.
Competitive Landscape
The global embolotherapy market is quite competitive with some key competitors like Boston Scientific Corporation, Merit Medical Systems, Terumo Corporation, Medtronic plc, Johnson & Johnson, Stryker Corporation, BTG plc, Penumbra, Inc., Cook Medical, Abbott Laboratories. The growth of these companies is attributed to product launch, acquisition of independent companies, and investments in multiple sectors.
For example, Terumo acquired the 3M Company's cardiovascular division in July 1999 and founded Terumo Cardiovascular Systems Corp. in the USA. The company made two more acquisitions in 2001: it acquired Sumitomo Bakelite Co., Ltd.'s home oxygen division, and founded Japan's Terumo Medical Care K.K. and Ikiken Co., Ltd., and more.
Topic's you may be interested, Hematocrit Test Devices Market, Hematology Testing Products Market, Haemodialysis Equipment Market, Infectious Disease Testing Products Market, Cardiometabolic Monitoring Products Market
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results